Getwell Hospital & Research Institute

Details Doctors
Medical Suppliers In Maharashtra

Name :

Getwell Hospital & Research Institute

Address  :

Plot No 20/A,
Behind Vijayanand Society,
20/1, Dr. Khare Marg,
Dhantoli,

Town  :

Nagpur

State  :

Maharashtra

Country  :

INDIA

Post Code:

440012

Phone  :

(+91)7126632200

Fax  :

0712-2441046

Web URL  :

Available

Email  :

admin@getwellhospitals.com
Getwell Hospital Research Institute
Specialization
  • Anaesthesiology
  • Cancer Surgery
  • Dermatology
  • Endocrinology
  • ENT
  • Gastro-enterology
  • General Medicine
  • General Surgeon
  • Gynaecology
  • Hematologist
  • Intensive Care Unit
  • Microbiology
  • Minimal Access Surgery
  • Neuro Surgery
  • Neurologist
  • Ophthalmology
  • Orthodontist
  • Orthopedics
  • Paediatrics
  • Pathology Lab
  • Plastic Surgery
  • Psychiatrist
  • Pulmonology
  • Urology
Facilities

ICU Beds : 10

Advance Facility

  • Medicine Facility
  • Medical Stores

History
A hospital which will make any corporate house proud but without any corporate backing A hospital created by a group of self made dedicated professionals each of whom has established himself in Nagpur through sheer hardwork and sincerity A Hospital which lacks in nothing when it comes to giving the best healh care available in the country and a hospital which has the widest base of full time dedicated Super specialists who complement each other

A hospital which counts its earnings in smiles created rather than the profits earned
NEWS
Early detection can prevent most cancers from turning deadly report

Most cancers that kill Indians oral cavity breast cervical are preventable if detected at an early stage said doctors who conducted the study on cancerrelated deaths in India The study was published in The Lancet on Wednesday In 2010 23 of cancer deaths among men were because of oral cavity cancers Among women 17 of the deaths were because of ... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More